Asia Pacific Cell Therapy Market Size [2028] To Reach USD 2.9 BillionPosted by rahul nikade on September 28th, 2022 Asia Pacific Cell Therapy Industry Overview The Asia Pacific cell therapy market size was valued at USD 959.8 million in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 14.9% from 2021 to 2028. The development of stem cell banking facilities and the resultant increase in stem cell production is expected to improve the volumetric capabilities of the market at a regional and country level. This, in turn, is anticipated to drive the market. Moreover, advancements in the therapy landscape with respect to their efficiency and manufacturing are some other major drivers of the market. Gather more insights about the market drivers, restrains and growth of the Asia Pacific Cell Therapy Market
The outbreak of the SARS-CoV-2 pandemic has further driven the market as currently, there are no robust treatments for infection treatment, particularly in severe cases. A broad range of differences in the clinical symptoms of patients is primarily due to the genomic variations. Therefore, personalized treatment including cell therapies is recognized as a viable treatment approach in improving these symptoms.
Also, rising clinical studies on exosomes to treat COVID-19 are expected to boost the market growth over the forecast period. For instance, Shanghai Public Health Clinical Center collaborated with Wuhan Jinyintan Hospital and Cellular Biomedicine Group Ltd. in February 2020 to perform clinical trials for inhalation of MSCs-derived exosomes to treat coronavirus. A rise in approval, as well as adoption of regenerative medicine across several Asian countries, is expected to boost the revenue generation of the market.
Grand View Research has segmented the Asia Pacific cell therapy market on the basis of use-type, therapy type, and country: Asia Pacific Cell Therapy Use-type Outlook (Revenue, USD Million, 2017 - 2028)
Asia Pacific Cell Therapy Type Outlook (Revenue, USD Million, 2017 - 2028)
Asia Pacific Cell Therapy Country Outlook (Revenue, USD Million, 2017 - 2028)
Market Share Insights
Key Companies profiled: Some of the prominent players in the Asia Pacific cell therapy market include:
Order a free sample PDF of the Asia Pacific Cell Therapy Market Intelligence Study, published by Grand View Research.
Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead. Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc. Phone: 1-415-349-0058 Toll Free: 1-888-202-9519 Email: sales@grandviewresearch.com Web: https://www.grandviewresearch.com
Like it? Share it!More by this author |